Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine Ophtesic Gel Versus Subconjunctival Xylocaine Injection in Pterygium Excision
NCT05978687Phase 4Completed
- Sponsor
- Vrije Universiteit Brussel
- Start
- Sep 2023
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of lidocaine 10% oropharyngeal spray in pterygium (2 arms), sponsored by Vrije Universiteit Brussel. Primary endpoint: Ocular Surface Disease Index Score at 8 days. Started Sep 2023; status: completed.
02
Drugs
lidocaine 10% oropharyngeal spray
03
Conditions
pterygium
Beyond the preview
Go deeper on NCT05978687.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05978687.